Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)

Seoul National University Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
dlbcl, tislelizumab, pemetrexed, relapsed or refractory primary diffuse large b-cell lymphoma, r/r primary dlbcl, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 892830
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.